En el próximo capítulo de Sueños de libertad.... Andrés tratará de hacer ver a su padre que Gabriel cometió un sabotaje en la fábrica y que está detrás del robo del perfume de Cobeaga. El patriarca ...
Series TVE desvela por error el final de temporada de La Promesa y anticipa doble sesión para la Navidad Series Avance semanal de 'Sueños de libertad', del 22 al 26 ...
Avance de 'Valle Salvaje', capítulo 321 de hoy, martes 23 de diciembre: El plan para liberar a Luisa
Series Avance semanal de 'Valle Salvaje' del 22 al 26 de diciembre: Leonardo se marcha, el duque habla con el juez y Matilde y Atanasio llegan a su boda Series Avance semanal de 'La Promesa' del 22 al ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The 75,000-square-foot building ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
(RTTNews) - Axogen, Inc. (AXGN) announced that the U.S. Food and Drug Administration has approved the Biologics License Application (BLA) for AVANCE, an acellular nerve allograft (arwx). AXGN closed ...
ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of ...
Clinical trial findings showed Avance was noninferior to a collagen nerve cuff for returning sensory function in patients with nerve injuries in the hand. The Food and Drug Administration (FDA) has ...
The U.S. FDA granted accelerated approval for the Biologics License Application for Axogen Inc.'s Avance, an acellular nerve allograft that serves as a scaffold for nerve regrowth, for treatment of ...
Avance Biosciences opened its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company’s capabilities in potency and functional ...
Dec 3 (Reuters) - The U.S. Food and Drug Administration has approved Axogen's (AXGN.O), opens new tab nerve repair graft, the health regulator said on Wednesday, paving the way for 12 years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results